期刊文献+

莱克多巴胺多克隆抗体的制备 被引量:13

Preparation of anti-ractopamine polyclonal antibodies
在线阅读 下载PDF
导出
摘要 采用多元酸酐法活化盐酸莱克多巴胺,用混合酸酐法将活化的莱克多巴胺与载体蛋白(KLH,BSA)偶联,制备了莱克多巴胺免疫原KLH-Rac和包被抗原BSA-Rac。以KLH-Rac免疫新西兰白兔获得了莱克多巴胺多克隆抗体,以BSA-Rac为包被抗原,采用间接ELISA检测抗血清,其效价达到1∶6 000,间接竞争ELISA测得抗血清的IC50值约为5 ng/mL,其与克伦特罗、沙丁胺醇、特布它林的交叉反应性小于0.01%。 Ractopamine HC1 was activated by the multi-anhydride method and the activated ractopamine was conjugated to a carrier protein by the mixed-anhydride method. The carrier protein was keyhole limpet hemocyanin(KLH) and bovine serum albumin(BSA). The KLH conjugate(KLH-Rac) was used as immunogen and the BSA conjugate(BSA-Rac) was used as the coating antigen for the development of an ELISA. New Zealand rabbits were immunized with KLH-Rac. Titer of the polyclonal antiserum detected by the developed indirect ELISA method was more than 6,000. The antiserum IC50 detected by an indirect competitive ELISA was approximately 5 ng/mL. The cross reactivity with clenbuterol,salbutamol and terbutaline was less then 0.01%.
出处 《中国兽医科学》 CAS CSCD 北大核心 2006年第1期62-65,共4页 Chinese Veterinary Science
基金 农业部"948"项目(2003-Q08)
关键词 莱克多巴胺 半抗原 ELISA 抗体 ractopamine hapten ELISA antibody
  • 相关文献

参考文献12

  • 1[1]Peter T A,William G H,Lorie C P,et al.Ractopamine increases total and myofibrillar protein synthesis in cultured rat myotubes metabolism and hormonal regulation[J].Journal of Nutrition,1990,120:1677-1683.
  • 2[2]Smith D J,Shelver W L.Tissue residues of ractopamine and urinary excretion of ractopamine and metabolites in animals treated for 7 days with dietary ractopamine[J].Journal of Animal Science,2002,80:1240-1249.
  • 3[3]Shappell N W,Feil V J,Smith D J,et al.Response of C2C12 mouse and turkey skeletal muscle cells to the β-adrenergic agonist ractopamine[J].Journal of Animal Science,2000,78:699-708.
  • 4[4]Bark L J,Stahly T S,Cromwell G L,et al.Influence of genetic capacity for lean tissue growth on rate and efficiency of tissue accretion in pigs fed ractopamine[J].Journal of Animal Science,1992,70:3391-3400.
  • 5[5]Mitchell G A,Dunnavan G.Illegal use of β-adrenergic agonist in the united states[J].Journal of Animal Science,1998,76:208-211.
  • 6[6]Kuiper H A,Noordam M Y,Roos A H,et al.Illegal use of β-adrenergic agonist:european community[J].Journal of Animal Science,1998,76:195-207.
  • 7[7]Meyer H H D,Rinke L,Dursch I.Residue screening for the β-agonists clenbuterol,salbutamol and cimaterol in urine using enzyme immunoassay and high performance liquid chromatography[J].Journal of Chromatography,1991,564:551-556.
  • 8[8]Shelver W L,Smith D J,Berry E S.Production and characte-rization of a monoclonal antibody against the β-adrenergic agonist ractopamine[J].Journal of Agricultural and Food Chemistry,2000,48:4020-4026.
  • 9[9]Shelver W L,Smith D J.Development of an immunoassay for the β-adrenergic agonist ractopamine[J].Journal of Immunoassay,2000,21(1):1-23.
  • 10[11]Brunswick D J,Needelman B,Mendels J.Radioimmunoassay of imipramine and desmethylimipraamine[J].Life Sciences,1978,22:137-146.

同被引文献118

引证文献13

二级引证文献55

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部